Breaking Barriers: Reducing Costs and Overcoming Challenges in <i>BCR::ABL-1</i> Monitoring for Chronic Myeloid Leukemia in Brazil

PURPOSE: test in a tertiary academic reference care center in Brazil and simulated alternatives to increase patient access to the test. METHODS: This is an economic analysis that estimates the costs based on resource consumption from a hospital to deliver a specific health care service, following the steps of the time-driven activity-based costing method at an academic reference center in Brazil. With the costs per test calculated, a scenario analysis estimated the budget impact resulting from an increase in test volume and a decrease in kit purchase cost, considering the local incidence of the disease. RESULTS: The cost per test was R$717, and if only laboratory reagents and personnel were considered, delivering the test to one patient accounted for R$556, whereas the current reimbursement fee is R$144. The simulated scenarios indicate that by increasing the volume of tests delivered by 60% and renegotiating the acquisition cost with the supplier in the same proportion, it is possible to cover 63% of the regional demand without increasing the budget impact. CONCLUSION: test with financial accountability.